Journal of Neuromuscular Diseases

Title Publication Date Language Citations
Current Classification and Management of Inflammatory Myopathies2018/05/299
The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature2015/01/015
Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 – A Prospective Observational Study2019/10/315
Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service2019/05/214
Advances in Treatment of Spinal Muscular Atrophy – New Phenotypes, New Challenges, New Implications for Care2020/01/224
Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease – A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI2019/01/303
Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative?2015/10/073
Feeding and Swallowing Disorders in Pediatric Neuromuscular Diseases: An Overview2015/11/203
Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis2019/05/213
Anti-HMGCR Myopathy2018/02/213
Analysis of Azithromycin Monohydrate as a Single or a Combinatorial Therapy in a Mouse Model of Severe Spinal Muscular Atrophy2017/08/293
Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy2021/01/013
Compliance to Care Guidelines for Duchenne Muscular Dystrophy2015/01/013
Integrin dysregulation as a possible driver of matrix remodeling in Laminin-deficient congenital muscular dystrophy (MDC1A)2015/01/013
Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls2021/07/303
Exon-Skipping in Duchenne Muscular Dystrophy2021/11/302
Macrophages in Skeletal Muscle Dystrophies, An Entangled Partner2022/01/042
A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 12018/08/022
Safety Monitoring of Gene Therapy for Spinal Muscular Atrophy with Onasemnogene Abeparvovec –A Single Centre Experience2021/03/022
Genetic Modifiers for Neuromuscular Diseases2014/01/012
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome2020/06/022
Feeding and Swallowing Problems in Infants with Spinal Muscular Atrophy Type 1: an Observational Study2020/06/022
Prospective Cohort Study of Nusinersen Treatment in Adults with Spinal Muscular Atrophy2020/06/022
Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada2021/07/302
Type 0 Spinal Muscular Atrophy: Further Delineation of Prenatal and Postnatal Features in 16 Patients2016/11/292
Defects in Axonal Transport in Inherited Neuropathies2019/10/312
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening2018/05/292
Orphan Peripheral Neuropathies2021/01/012
Sarcomere Dysfunction in Nemaline Myopathy2017/05/302
Molecular Mechanisms of Skeletal Muscle Hypertrophy2021/03/022